Does Cardiorespiratory Interval Training Improve Post-stroke Fatigue

Launched by UMEÅ UNIVERSITY · Mar 2, 2018

Keywords

ClinConnect Summary

This clinical trial is studying whether a special exercise program called cardiorespiratory interval training can help reduce fatigue in people who have recently had a stroke. Fatigue is a common issue after a stroke and can make recovery harder. The trial will involve 50 participants who will be divided into two groups. One group will do the cardiorespiratory interval training three times a week for eight weeks, while the other group will receive standard care. Researchers want to see if those who participate in the exercise program experience less fatigue compared to those who don’t.

To be eligible for the trial, participants must be between the ages of 65 and 74 and have had an acute stroke, with certain medical conditions ruled out, such as severe strokes or serious heart issues. They should also be able to live independently and cycle on a stationary bike. Participants can expect to be involved for about two months, and their fatigue levels will be measured at the start and end of the trial to see if the exercise program made a difference. This study may provide valuable insights into new ways to help stroke survivors manage fatigue and improve their overall recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Preliminary or final diagnosis of acute stroke due to Brain infarction: large vessel disease, lacunar syndrome, cryptogenic stroke Intracerebral hemorrhage
• • Post-stroke fatigue (defined as a summation score of 28 or more on the S-FAS)
• • Medical stability
• • Independent living in Umeå or Gävle (in the nearby surrounding areas) and able to cycle an ergometer cycle.
• Exclusion Criteria:
• • Patients with severe stroke with modified Rankin Scale \>3
• • Atrial fibrillation, pacemaker or other arrhythmia which exclude reliable monitoring of heart-frequency
• • Unstable pulmonary or cardiac disease
• • Serious co-morbidity with for example terminal cancer, hemodialysis, severe cognitive dysfunction with Montreal Cognitive Assessment (MOCA) ≤ 26
• • Drug abuse
• • Patients living far away from the hospital or in residential care facilities.